Last updated at 30 Jul 2024 06:52 PM
Director
DIN: 03179738
Ramesh Reddy Guntaka is currently associated with 3 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at OSTRICH PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03179738.Ramesh Reddy Guntaka is currently involved in 2 different roles. Their most recent position is with ARKI MEDTECH PRIVATE LIMITED as a Individual Subscriber. The first company Ramesh Reddy Guntaka was appointed to as a director was OSTRICH PHARMACEUTICALS PRIVATE LIMITED. Ramesh Reddy Guntaka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ramesh Reddy Guntaka is currently associated with 3 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at OSTRICH PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03179738.Ramesh Reddy Guntaka is currently involved in 2 different roles. Their most recent position is with ARKI MEDTECH PRIVATE LIMITED as a Individual Subscriber. The first company Ramesh Reddy Guntaka was appointed to as a director was OSTRICH PHARMACEUTICALS PRIVATE LIMITED. Ramesh Reddy Guntaka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
2y 10m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| OSTRICH PHARMACEUTICALS PRIVATE LIMITED | Director | 24-Nov-2011 |
| RIVAAN HEALTHCARE PRIVATE LIMITED | Individual Subscriber | 15-Jul-2024 |
| ARKI MEDTECH PRIVATE LIMITED | Individual Subscriber | 18-Jul-2024 |